[English] 日本語
Yorodumi
- PDB-3rul: New strategy to analyze structures of glycopeptide-target complexes -

+
Open data


ID or keywords:

Loading...

-
Basic information

Entry
Database: PDB / ID: 3rul
TitleNew strategy to analyze structures of glycopeptide-target complexes
Components
  • Dalbavancin
  • Ubiquitin
KeywordsSignaling Protein/Antibiotic / antibiotic / glycopeptide / native protein ligation / fusion / carboxymethylation of cysteine / dalbavancin / Signaling Protein-Antibiotic complex
Function / homology
Function and homology information


Maturation of protein E / Maturation of protein E / ER Quality Control Compartment (ERQC) / Myoclonic epilepsy of Lafora / FLT3 signaling by CBL mutants / Prevention of phagosomal-lysosomal fusion / IRAK2 mediated activation of TAK1 complex / Alpha-protein kinase 1 signaling pathway / Glycogen synthesis / IRAK1 recruits IKK complex ...Maturation of protein E / Maturation of protein E / ER Quality Control Compartment (ERQC) / Myoclonic epilepsy of Lafora / FLT3 signaling by CBL mutants / Prevention of phagosomal-lysosomal fusion / IRAK2 mediated activation of TAK1 complex / Alpha-protein kinase 1 signaling pathway / Glycogen synthesis / IRAK1 recruits IKK complex / IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation / Membrane binding and targetting of GAG proteins / Endosomal Sorting Complex Required For Transport (ESCRT) / Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 / Negative regulation of FLT3 / PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 / Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation / Constitutive Signaling by NOTCH1 HD Domain Mutants / IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation / NOTCH2 Activation and Transmission of Signal to the Nucleus / TICAM1,TRAF6-dependent induction of TAK1 complex / TICAM1-dependent activation of IRF3/IRF7 / APC/C:Cdc20 mediated degradation of Cyclin B / Regulation of FZD by ubiquitination / Downregulation of ERBB4 signaling / p75NTR recruits signalling complexes / APC-Cdc20 mediated degradation of Nek2A / Regulation of innate immune responses to cytosolic DNA / TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling / InlA-mediated entry of Listeria monocytogenes into host cells / TRAF6-mediated induction of TAK1 complex within TLR4 complex / Regulation of pyruvate metabolism / NF-kB is activated and signals survival / Downregulation of ERBB2:ERBB3 signaling / Pexophagy / NRIF signals cell death from the nucleus / VLDLR internalisation and degradation / Regulation of PTEN localization / Activated NOTCH1 Transmits Signal to the Nucleus / Synthesis of active ubiquitin: roles of E1 and E2 enzymes / Regulation of BACH1 activity / TICAM1, RIP1-mediated IKK complex recruitment / MAP3K8 (TPL2)-dependent MAPK1/3 activation / Translesion synthesis by REV1 / Translesion synthesis by POLK / Downregulation of TGF-beta receptor signaling / Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) / InlB-mediated entry of Listeria monocytogenes into host cell / Regulation of activated PAK-2p34 by proteasome mediated degradation / Josephin domain DUBs / Translesion synthesis by POLI / JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 / IKK complex recruitment mediated by RIP1 / Gap-filling DNA repair synthesis and ligation in GG-NER / PINK1-PRKN Mediated Mitophagy / TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) / TNFR1-induced NF-kappa-B signaling pathway / Autodegradation of Cdh1 by Cdh1:APC/C / APC/C:Cdc20 mediated degradation of Securin / N-glycan trimming in the ER and Calnexin/Calreticulin cycle / TCF dependent signaling in response to WNT / Asymmetric localization of PCP proteins / Ubiquitin-dependent degradation of Cyclin D / SCF-beta-TrCP mediated degradation of Emi1 / Regulation of NF-kappa B signaling / NIK-->noncanonical NF-kB signaling / TNFR2 non-canonical NF-kB pathway / activated TAK1 mediates p38 MAPK activation / Negative regulators of DDX58/IFIH1 signaling / AUF1 (hnRNP D0) binds and destabilizes mRNA / Vpu mediated degradation of CD4 / NOTCH3 Activation and Transmission of Signal to the Nucleus / Assembly of the pre-replicative complex / Degradation of DVL / Ubiquitin Mediated Degradation of Phosphorylated Cdc25A / Deactivation of the beta-catenin transactivating complex / Regulation of signaling by CBL / Cdc20:Phospho-APC/C mediated degradation of Cyclin A / Dectin-1 mediated noncanonical NF-kB signaling / Fanconi Anemia Pathway / Negative regulation of FGFR3 signaling / Peroxisomal protein import / Degradation of AXIN / Hh mutants are degraded by ERAD / Stabilization of p53 / Regulation of TNFR1 signaling / Negative regulation of FGFR2 signaling / Activation of NF-kappaB in B cells / Degradation of GLI1 by the proteasome / EGFR downregulation / Negative regulation of FGFR4 signaling / Downregulation of SMAD2/3:SMAD4 transcriptional activity / Hedgehog ligand biogenesis / G2/M Checkpoints / Negative regulation of FGFR1 signaling / Termination of translesion DNA synthesis / Defective CFTR causes cystic fibrosis / Recognition of DNA damage by PCNA-containing replication complex / Negative regulation of NOTCH4 signaling / GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2
Similarity search - Function
Phosphatidylinositol 3-kinase Catalytic Subunit; Chain A, domain 1 / : / Ubiquitin domain signature. / Ubiquitin conserved site / Ubiquitin domain / Ubiquitin-like (UB roll) / Ubiquitin family / Ubiquitin homologues / Ubiquitin domain profile. / Ubiquitin-like domain ...Phosphatidylinositol 3-kinase Catalytic Subunit; Chain A, domain 1 / : / Ubiquitin domain signature. / Ubiquitin conserved site / Ubiquitin domain / Ubiquitin-like (UB roll) / Ubiquitin family / Ubiquitin homologues / Ubiquitin domain profile. / Ubiquitin-like domain / Ubiquitin-like domain superfamily / Roll / Alpha Beta
Similarity search - Domain/homology
10-METHYLUNDECANOIC ACID / alpha-D-mannopyranose / 2-amino-2-deoxy-beta-D-glucopyranuronic acid / L(+)-TARTARIC ACID / Polyubiquitin-C
Similarity search - Component
Biological speciesHomo sapiens (human)
MethodX-RAY DIFFRACTION / SYNCHROTRON / MOLECULAR REPLACEMENT / molecular replacement / Resolution: 2.5 Å
AuthorsEconomou, N.J. / Nahoum, V. / Weeks, S.D. / Grasty, K.C. / Loll, P.J.
CitationJournal: J.Am.Chem.Soc. / Year: 2012
Title: A carrier protein strategy yields the structure of dalbavancin.
Authors: Economou, N.J. / Nahoum, V. / Weeks, S.D. / Grasty, K.C. / Zentner, I.J. / Townsend, T.M. / Bhuiya, M.W. / Cocklin, S. / Loll, P.J.
History
DepositionMay 5, 2011Deposition site: RCSB / Processing site: RCSB
Revision 1.0Jun 6, 2012Provider: repository / Type: Initial release
Revision 2.0Jul 29, 2020Group: Atomic model / Data collection ...Atomic model / Data collection / Derived calculations / Polymer sequence / Structure summary
Category: atom_site / chem_comp ...atom_site / chem_comp / entity / entity_poly / pdbx_chem_comp_identifier / pdbx_entity_nonpoly / struct_conn / struct_site / struct_site_gen
Item: _atom_site.auth_atom_id / _atom_site.label_atom_id ..._atom_site.auth_atom_id / _atom_site.label_atom_id / _chem_comp.name / _chem_comp.type / _entity.pdbx_description / _entity_poly.pdbx_seq_one_letter_code_can / _pdbx_entity_nonpoly.name / _struct_conn.pdbx_dist_value / _struct_conn.pdbx_leaving_atom_flag / _struct_conn.ptnr1_auth_asym_id / _struct_conn.ptnr1_auth_comp_id / _struct_conn.ptnr1_auth_seq_id / _struct_conn.ptnr1_label_asym_id / _struct_conn.ptnr1_label_atom_id / _struct_conn.ptnr1_label_comp_id / _struct_conn.ptnr1_label_seq_id / _struct_conn.ptnr2_auth_asym_id / _struct_conn.ptnr2_auth_comp_id / _struct_conn.ptnr2_auth_seq_id / _struct_conn.ptnr2_label_asym_id / _struct_conn.ptnr2_label_atom_id / _struct_conn.ptnr2_label_comp_id / _struct_conn.ptnr2_label_seq_id
Description: Carbohydrate remediation / Provider: repository / Type: Remediation
Revision 2.1Sep 13, 2023Group: Data collection / Database references ...Data collection / Database references / Refinement description / Structure summary
Category: chem_comp / chem_comp_atom ...chem_comp / chem_comp_atom / chem_comp_bond / database_2 / pdbx_initial_refinement_model
Item: _chem_comp.pdbx_synonyms / _database_2.pdbx_DOI / _database_2.pdbx_database_accession
Revision 2.2Dec 6, 2023Group: Data collection / Derived calculations / Category: chem_comp_atom / chem_comp_bond / struct_conn
Item: _chem_comp_atom.atom_id / _chem_comp_bond.atom_id_2 / _struct_conn.pdbx_leaving_atom_flag

-
Structure visualization

Structure viewerMolecule:
MolmilJmol/JSmol

Downloads & links

-
Assembly

Deposited unit
A: Ubiquitin
B: Ubiquitin
C: Ubiquitin
D: Ubiquitin
E: Dalbavancin
F: Dalbavancin
G: Dalbavancin
H: Dalbavancin
hetero molecules


Theoretical massNumber of molelcules
Total (without water)43,89625
Polymers40,9668
Non-polymers2,93017
Water27015
1
A: Ubiquitin
E: Dalbavancin
hetero molecules


Theoretical massNumber of molelcules
Total (without water)11,1157
Polymers10,2412
Non-polymers8745
Water181
TypeNameSymmetry operationNumber
identity operation1_555x,y,z1
2
B: Ubiquitin
F: Dalbavancin
hetero molecules


Theoretical massNumber of molelcules
Total (without water)11,1518
Polymers10,2412
Non-polymers9096
Water181
TypeNameSymmetry operationNumber
identity operation1_555x,y,z1
3
C: Ubiquitin
G: Dalbavancin
hetero molecules


Theoretical massNumber of molelcules
Total (without water)10,8155
Polymers10,2412
Non-polymers5743
Water362
TypeNameSymmetry operationNumber
identity operation1_555x,y,z1
4
D: Ubiquitin
H: Dalbavancin
hetero molecules


Theoretical massNumber of molelcules
Total (without water)10,8155
Polymers10,2412
Non-polymers5743
Water362
TypeNameSymmetry operationNumber
identity operation1_555x,y,z1
Unit cell
Length a, b, c (Å)53.300, 86.250, 107.190
Angle α, β, γ (deg.)90.000, 90.000, 90.000
Int Tables number19
Space group name H-MP212121
Noncrystallographic symmetry (NCS)NCS domain:
IDEns-ID
11
21
31
41
12
22
32
42
13
23
33
43
14
24
34
44
15
25
35
45
16
26
36
46
17
27

NCS domain segments:
Dom-IDComponent-IDEns-IDSelection details
111chain A and resseq 1:16
211chain B and resseq 1:16
311chain C and resseq 1:16
411chain D and resseq 3:15
112chain A and resseq 17:24
212chain B and resseq 17:24
312chain C and resseq 17:24
412chain D and resseq 17:24
113chain A and resseq 26:32
213chain B and resseq 26:32
313chain C and resseq 26:32
413chain D and resseq 26:32
114chain A and resseq 34:39
214chain B and resseq 34:39
314chain C and resseq 34:39
414chain D and resseq 34:39
115chain A and resseq 41:71
215chain B and resseq 41:71
315chain C and resseq 41:71
415chain D and resseq 41:71
116chain A and resseq 74:77
216chain B and resseq 74:77
316chain C and resseq 74:77
416chain D and resseq 74:77
117chain F and resseq 1:7
217chain G and resseq 1:7

NCS ensembles :
ID
1
2
3
4
5
6
7

NCS oper:
IDCodeMatrixVector
1given(0.042641, 0.332348, 0.942193), (0.337421, -0.892431, 0.299524), (0.940388, 0.305143, -0.150195)-43.871399, 0.666808, 48.018398
2given(0.290096, 0.319267, 0.902171), (-0.233893, -0.890468, 0.390334), (0.927975, -0.324246, -0.183647)-26.215599, -39.216099, 7.45685
3given(0.804344, -0.593734, -0.022592), (0.59049, 0.803015, -0.080544), (0.065963, 0.051444, 0.996495)-51.0173, 28.845301, 9.31183
4given(0.01953, 0.318639, 0.947675), (0.342244, -0.892724, 0.29311), (0.939408, 0.318611, -0.126487)-44.957001, 0.830295, 47.217201
5given(0.279748, 0.336068, 0.899332), (-0.216497, -0.890524, 0.400121), (0.935345, -0.306636, -0.176365)-26.112801, -39.4147, 7.59471
6given(0.787644, -0.616079, -0.007991), (0.612367, 0.784199, -0.100194), (0.067994, 0.074024, 0.994936)-52.477299, 27.9182, 10.1973
7given(0.016811, 0.311385, 0.950135), (0.309728, -0.905148, 0.291161), (0.950677, 0.289389, -0.111661)-44.9533, -0.066506, 47.7626
8given(0.27034, 0.339946, 0.900751), (-0.248269, -0.879331, 0.406374), (0.930204, -0.333488, -0.15332)-25.796499, -39.091301, 6.83843
9given(0.823752, -0.565994, -0.032909), (0.562263, 0.823013, -0.08069), (0.072754, 0.047965, 0.996196)-49.475601, 30.0385, 8.74839
10given(0.04006, 0.301969, 0.952476), (0.306461, -0.911012, 0.275934), (0.95104, 0.280842, -0.129036)-44.083, 0.298121, 48.352299
11given(0.290098, 0.313157, 0.90431), (-0.275433, -0.877641, 0.392279), (0.916504, -0.362876, -0.168348)-26.6199, -38.732101, 6.45786
12given(0.809319, -0.587332, -0.006598), (0.585279, 0.807336, -0.075205), (0.049498, 0.057004, 0.997146)-50.599701, 29.1301, 9.37592
13given(0.034601, 0.32427, 0.945332), (0.32184, -0.899124, 0.296639), (0.946162, 0.293981, -0.135474)-44.241798, 0.113244, 48.200699
14given(0.278826, 0.334245, 0.900298), (-0.243291, -0.882309, 0.402915), (0.929013, -0.331377, -0.164692)-25.948601, -39.225899, 7.1527
15given(0.796158, -0.60508, 0.00341), (0.602643, 0.79242, -0.094301), (0.054357, 0.077134, 0.995538)-51.5462, 28.389601, 10.4575
16given(0.160661, 0.316142, 0.935009), (0.285563, -0.921689, 0.26257), (0.944797, 0.224819, -0.238358)-41.0406, 0.181438, 51.958302
17given(0.319211, 0.261264, 0.910959), (-0.31404, -0.877774, 0.36179), (0.894138, -0.401564, -0.198147)-29.0989, -37.470699, 6.05066
18given(0.8237, -0.563748, 0.060886), (0.56702, 0.818448, -0.092904), (0.002543, 0.111048, 0.993812)-50.802299, 29.8839, 12.6486
19given(0.804225, -0.59197, 0.052853), (0.594302, 0.800239, -0.080135), (0.005143, 0.095857, 0.995382)-52.039398, 27.682501, 11.7917

-
Components

-
Protein / Protein/peptide , 2 types, 8 molecules ABCDEFGH

#1: Protein
Ubiquitin


Mass: 8952.293 Da / Num. of mol.: 4
Source method: isolated from a genetically manipulated source
Source: (gene. exp.) Homo sapiens (human) / Gene: UBC / Production host: Escherichia coli (E. coli) / References: UniProt: P0CG48
#2: Protein/peptide
Dalbavancin


Mass: 1289.175 Da / Num. of mol.: 4 / Source method: obtained synthetically

-
Sugars , 2 types, 8 molecules

#5: Sugar
ChemComp-N1L / 2-amino-2-deoxy-beta-D-glucopyranuronic acid / 2-amino-2-deoxy-beta-D-glucuronic acid / 2-amino-2-deoxy-D-glucuronic acid / 2-amino-2-deoxy-glucuronic acid


Type: D-saccharide, beta linking / Mass: 193.155 Da / Num. of mol.: 4
Source method: isolated from a genetically manipulated source
Formula: C6H11NO6
IdentifierTypeProgram
b-D-GlcpANIUPAC CARBOHYDRATE SYMBOLPDB-CARE 1.0
#6: Sugar
ChemComp-MAN / alpha-D-mannopyranose / alpha-D-mannose / D-mannose / mannose


Type: D-saccharide, alpha linking / Mass: 180.156 Da / Num. of mol.: 4
Source method: isolated from a genetically manipulated source
Formula: C6H12O6
IdentifierTypeProgram
DManpaCONDENSED IUPAC CARBOHYDRATE SYMBOLGMML 1.0
a-D-mannopyranoseCOMMON NAMEGMML 1.0
a-D-ManpIUPAC CARBOHYDRATE SYMBOLPDB-CARE 1.0
ManSNFG CARBOHYDRATE SYMBOLGMML 1.0

-
Non-polymers , 4 types, 24 molecules

#3: Chemical
ChemComp-TLA / L(+)-TARTARIC ACID


Mass: 150.087 Da / Num. of mol.: 4 / Source method: obtained synthetically / Formula: C4H6O6
#4: Chemical ChemComp-CL / CHLORIDE ION


Mass: 35.453 Da / Num. of mol.: 1 / Source method: obtained synthetically / Formula: Cl
#7: Chemical
ChemComp-M12 / 10-METHYLUNDECANOIC ACID


Mass: 200.318 Da / Num. of mol.: 4 / Source method: obtained synthetically / Formula: C12H24O2
#8: Water ChemComp-HOH / water


Mass: 18.015 Da / Num. of mol.: 15 / Source method: isolated from a natural source / Formula: H2O

-
Details

Compound detailsDALBAVANCIN IS A TETRACYCLIC LIPOGLYCOPEPTIDE. THE SCAFFOLD IS A HEPTAPEPTIDE WITH THE ...DALBAVANCIN IS A TETRACYCLIC LIPOGLYCOPEPTIDE. THE SCAFFOLD IS A HEPTAPEPTIDE WITH THE CONFIGURATION D-D-L-D-D-L-L. IT IS FURTHER GLYCOSYLATED BY MONSACCHARIDES 2-AMINO-2-DEOXY-BETA- D-GLUCOPYRANURONIC ACIDRISTOSAMINE AND D-MANNOSE AND HAS FATTY ACID METHYLUNDECANOIC ACID. HERE, DALBAVANCIN IS REPRESENTED BY GROUPING TOGETHER THE SEQUENCE (SEQRES) AND THE THREE LIGANDS (HET) MAN, N1L, AND M12. GROUP: 1 NAME: DALBAVANCIN CHAIN: E, F, G, H COMPONENT_1: PEPTIDE LIKE SEQUENCE RESIDUES 1 TO 7 COMPONENT_2: SUGAR (2-AMINO-2-DEOXY-BETA-D-GLUCOPYRANURONIC ACID) COMPONENT_3: SUGAR (ALPHA-D-MANNOSE) COMPONENT_4: METHYLUNDECANOIC ACID DESCRIPTION: DALBAVANCIN IS A TETRACYCLIC LIPOGLYCOPEPTIDE, GLYCOSYLATED BY A MONOSACCHARIDE ON RESIDUE 4 (RESIDUE 8), AND A MONOSACCHARIDE ON RESIDUE 7 (RESIDUE 9) AND HAS FATTY ACID METHYLUNDECANOIC ACID (RESIDUE 10).
Sequence detailsTHE AUTHORS STATE THAT THESE RESIDUES ARE LIGATED NON-RECOMBINANTLY WITH NATIVE PROTEIN LIGATION ...THE AUTHORS STATE THAT THESE RESIDUES ARE LIGATED NON-RECOMBINANTLY WITH NATIVE PROTEIN LIGATION AFTER PROTEIN EXPRESSION AND PURIFICATION.

-
Experimental details

-
Experiment

ExperimentMethod: X-RAY DIFFRACTION / Number of used crystals: 1

-
Sample preparation

CrystalDensity Matthews: 3.23 Å3/Da / Density % sol: 61.94 %
Crystal growTemperature: 291 K / Method: vapor diffusion, hanging drop
Details: 24% PEG3350, 0.2M ammonium tartrate, 0.015M CYMAL-7, VAPOR DIFFUSION, HANGING DROP, temperature 291K

-
Data collection

DiffractionMean temperature: 93 K
Diffraction sourceSource: SYNCHROTRON / Site: NSLS / Beamline: X6A / Wavelength: 0.9537 Å
DetectorDate: Mar 2, 2010
RadiationProtocol: SINGLE WAVELENGTH / Monochromatic (M) / Laue (L): M / Scattering type: x-ray
Radiation wavelengthWavelength: 0.9537 Å / Relative weight: 1
ReflectionResolution: 2.5→19.6 Å / Num. all: 17703 / Num. obs: 16489 / % possible obs: 93.14 % / Observed criterion σ(F): 0 / Observed criterion σ(I): 0 / Redundancy: 16 % / Biso Wilson estimate: 50.76 Å2

-
Phasing

PhasingMethod: molecular replacement
Phasing MR
Highest resolutionLowest resolution
Rotation2.6 Å19.65 Å
Translation2.6 Å19.65 Å

-
Processing

Software
NameVersionClassificationNB
XSCALEdata scaling
MOLREPphasing
PHENIX1.6.2_432refinement
PDB_EXTRACT3.1data extraction
XDSdata reduction
RefinementMethod to determine structure: MOLECULAR REPLACEMENT
Starting model: PDB ENTRY 3ANJ

3anj


Resolution: 2.5→19.603 Å / Occupancy max: 1 / Occupancy min: 1 / SU ML: 0.31 / σ(F): 1.99 / Phase error: 31.9 / Stereochemistry target values: ML
RfactorNum. reflection% reflection
Rfree0.2774 907 5.14 %
Rwork0.2428 --
obs0.2445 17635 99.88 %
Solvent computationShrinkage radii: 0.95 Å / VDW probe radii: 1.2 Å / Solvent model: FLAT BULK SOLVENT MODEL / Bsol: 32.82 Å2 / ksol: 0.318 e/Å3
Displacement parameters
Baniso -1Baniso -2Baniso -3
1--21.8954 Å20 Å2-0 Å2
2--40.7618 Å20 Å2
3----18.8663 Å2
Refinement stepCycle: LAST / Resolution: 2.5→19.603 Å
ProteinNucleic acidLigandSolventTotal
Num. atoms2856 0 189 15 3060
Refine LS restraints
Refine-IDTypeDev idealNumber
X-RAY DIFFRACTIONf_bond_d0.0083112
X-RAY DIFFRACTIONf_angle_d1.2854236
X-RAY DIFFRACTIONf_dihedral_angle_d13.911268
X-RAY DIFFRACTIONf_chiral_restr0.083484
X-RAY DIFFRACTIONf_plane_restr0.008536
Refine LS restraints NCS
Ens-IDDom-IDAuth asym-IDNumberRefine-IDTypeRms dev position (Å)
11A126X-RAY DIFFRACTIONPOSITIONAL
12B126X-RAY DIFFRACTIONPOSITIONAL0.036
13C126X-RAY DIFFRACTIONPOSITIONAL0.034
14D100X-RAY DIFFRACTIONPOSITIONAL0.038
21A61X-RAY DIFFRACTIONPOSITIONAL
22B61X-RAY DIFFRACTIONPOSITIONAL0.023
23C61X-RAY DIFFRACTIONPOSITIONAL0.028
24D61X-RAY DIFFRACTIONPOSITIONAL0.021
31A55X-RAY DIFFRACTIONPOSITIONAL
32B55X-RAY DIFFRACTIONPOSITIONAL0.037
33C55X-RAY DIFFRACTIONPOSITIONAL0.035
34D55X-RAY DIFFRACTIONPOSITIONAL0.027
41A43X-RAY DIFFRACTIONPOSITIONAL
42B43X-RAY DIFFRACTIONPOSITIONAL0.037
43C43X-RAY DIFFRACTIONPOSITIONAL0.033
44D43X-RAY DIFFRACTIONPOSITIONAL0.032
51A252X-RAY DIFFRACTIONPOSITIONAL
52B252X-RAY DIFFRACTIONPOSITIONAL0.032
53C252X-RAY DIFFRACTIONPOSITIONAL0.034
54D252X-RAY DIFFRACTIONPOSITIONAL0.027
61A30X-RAY DIFFRACTIONPOSITIONAL
62B30X-RAY DIFFRACTIONPOSITIONAL0.033
63C30X-RAY DIFFRACTIONPOSITIONAL0.03
64D30X-RAY DIFFRACTIONPOSITIONAL0.036
71F84X-RAY DIFFRACTIONPOSITIONAL
72G84X-RAY DIFFRACTIONPOSITIONAL0.088
LS refinement shell
Resolution (Å)Rfactor RfreeNum. reflection RfreeRfactor RworkNum. reflection RworkRefine-ID% reflection obs (%)
2.5-2.65630.37711580.32072710X-RAY DIFFRACTION100
2.6563-2.86080.34481590.31952736X-RAY DIFFRACTION100
2.8608-3.14760.35971720.29262747X-RAY DIFFRACTION100
3.1476-3.60070.26831500.27912762X-RAY DIFFRACTION100
3.6007-4.52720.27421340.222817X-RAY DIFFRACTION100
4.5272-19.60320.21811340.20222956X-RAY DIFFRACTION100

+
About Yorodumi

-
News

-
Feb 9, 2022. New format data for meta-information of EMDB entries

New format data for meta-information of EMDB entries

  • Version 3 of the EMDB header file is now the official format.
  • The previous official version 1.9 will be removed from the archive.

Related info.:EMDB header

External links:wwPDB to switch to version 3 of the EMDB data model

-
Aug 12, 2020. Covid-19 info

Covid-19 info

URL: https://pdbj.org/emnavi/covid19.php

New page: Covid-19 featured information page in EM Navigator.

Related info.:Covid-19 info / Mar 5, 2020. Novel coronavirus structure data

+
Mar 5, 2020. Novel coronavirus structure data

Novel coronavirus structure data

Related info.:Yorodumi Speices / Aug 12, 2020. Covid-19 info

External links:COVID-19 featured content - PDBj / Molecule of the Month (242)：Coronavirus Proteases

+
Jan 31, 2019. EMDB accession codes are about to change! (news from PDBe EMDB page)

EMDB accession codes are about to change! (news from PDBe EMDB page)

  • The allocation of 4 digits for EMDB accession codes will soon come to an end. Whilst these codes will remain in use, new EMDB accession codes will include an additional digit and will expand incrementally as the available range of codes is exhausted. The current 4-digit format prefixed with “EMD-” (i.e. EMD-XXXX) will advance to a 5-digit format (i.e. EMD-XXXXX), and so on. It is currently estimated that the 4-digit codes will be depleted around Spring 2019, at which point the 5-digit format will come into force.
  • The EM Navigator/Yorodumi systems omit the EMD- prefix.

Related info.:Q: What is EMD? / ID/Accession-code notation in Yorodumi/EM Navigator

External links:EMDB Accession Codes are Changing Soon! / Contact to PDBj

+
Jul 12, 2017. Major update of PDB

Major update of PDB

  • wwPDB released updated PDB data conforming to the new PDBx/mmCIF dictionary.
  • This is a major update changing the version number from 4 to 5, and with Remediation, in which all the entries are updated.
  • In this update, many items about electron microscopy experimental information are reorganized (e.g. em_software).
  • Now, EM Navigator and Yorodumi are based on the updated data.

External links:wwPDB Remediation / Enriched Model Files Conforming to OneDep Data Standards Now Available in the PDB FTP Archive

-
Yorodumi

Thousand views of thousand structures

  • Yorodumi is a browser for structure data from EMDB, PDB, SASBDB, etc.
  • This page is also the successor to EM Navigator detail page, and also detail information page/front-end page for Omokage search.
  • The word "yorodu" (or yorozu) is an old Japanese word meaning "ten thousand". "mi" (miru) is to see.

Related info.:EMDB / PDB / SASBDB / Comparison of 3 databanks / Yorodumi Search / Aug 31, 2016. New EM Navigator & Yorodumi / Yorodumi Papers / Jmol/JSmol / Function and homology information / Changes in new EM Navigator and Yorodumi

Read more